HIV drug Aptivus gains new indication approval for kids

Article

Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.

Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
© 2024 MJH Life Sciences

All rights reserved.